chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram cerebral normal, Arteriogram carotid normal, Back pain, Bladder catheterisation, Blood lactate dehydrogenase normal
Clinical narrative: Patient is a 83 y.o. female patient of with history of CAD with stents ,hypertension ,anxiety, diastolic CHF, hyperlipidemia,and seizures presented to Hospital with leg weakness, fever, nasal congestin and was found to have COVID 19 infection, her husband also has COVID 19.    Lower extremity weakness r/o CVA SIRS Fever-resolved Acute on Chronic low back pain T-max 101.2 CT brain - negative for acute process MRI brain-no acute intracranial process or recent infarction CTA head/neck- no acute intracranial process UA- negative Urine Cx-negative Neurology signed off- follow up as needed PT/OT Care management Monitor CBC   Covid-19 Virus Infection Date of onset of symptoms: 10/21/22 Symptoms present on admission: yes Date of covid positive test: 10/21/22 Vaccination status: vaccinated Imaging: Chest x-ray-no focal pneumonia Oxygen requirements on admission: none Current oxygen requirements: none Medical therapy:Remdesivir-completed 3 days Consultants following: ID consulted Anticipated special isolation end date: 10/31/22   CRP, (86) Sedrate (41) D-dimer (0.57) ferritin(424) LDH (174) Sputum Cx-normal flora, many WBC Incentive Spirometry pen Inhalers prn Oxygen prn Encourage prone positioning   CAD Hypertension Hyperlipidemia History of stents 7 years ago Continue ASA, Losartan,  Plavix, Crestor Monitor BP, BP stable   Chronic Diastolic CHF Echocardiogram-pending- previous Echo 3/5/21-left ventricular diastolic function is grade 1, EF 58% Continue Lasix, Spirolactone Daily weights Strict I & O's   History of seizures Last seizure 15 years ago Continue Dilantin Seizure precautions Neurology -signed off follow up as needed   Incomplete micturition Patient void spontaneously however has to self cath twice a day and this has prevented her from having recurrent UTIs per urology Patient remains on low-dose trimethoprim daily No urinary symptoms
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: C-reactive protein increased, COVID-19, Chest X-ray normal, Computerised tomogram head normal, Culture urine negative
Clinical narrative: Patient is a 83 y.o. female patient of with history of CAD with stents ,hypertension ,anxiety, diastolic CHF, hyperlipidemia,and seizures presented to Hospital with leg weakness, fever, nasal congestin and was found to have COVID 19 infection, her husband also has COVID 19.    Lower extremity weakness r/o CVA SIRS Fever-resolved Acute on Chronic low back pain T-max 101.2 CT brain - negative for acute process MRI brain-no acute intracranial process or recent infarction CTA head/neck- no acute intracranial process UA- negative Urine Cx-negative Neurology signed off- follow up as needed PT/OT Care management Monitor CBC   Covid-19 Virus Infection Date of onset of symptoms: 10/21/22 Symptoms present on admission: yes Date of covid positive test: 10/21/22 Vaccination status: vaccinated Imaging: Chest x-ray-no focal pneumonia Oxygen requirements on admission: none Current oxygen requirements: none Medical therapy:Remdesivir-completed 3 days Consultants following: ID consulted Anticipated special isolation end date: 10/31/22   CRP, (86) Sedrate (41) D-dimer (0.57) ferritin(424) LDH (174) Sputum Cx-normal flora, many WBC Incentive Spirometry pen Inhalers prn Oxygen prn Encourage prone positioning   CAD Hypertension Hyperlipidemia History of stents 7 years ago Continue ASA, Losartan,  Plavix, Crestor Monitor BP, BP stable   Chronic Diastolic CHF Echocardiogram-pending- previous Echo 3/5/21-left ventricular diastolic function is grade 1, EF 58% Continue Lasix, Spirolactone Daily weights Strict I & O's   History of seizures Last seizure 15 years ago Continue Dilantin Seizure precautions Neurology -signed off follow up as needed   Incomplete micturition Patient void spontaneously however has to self cath twice a day and this has prevented her from having recurrent UTIs per urology Patient remains on low-dose trimethoprim daily No urinary symptoms
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Echocardiogram, Ejection fraction normal, Fibrin D dimer, Full blood count, Incentive spirometry
Clinical narrative: Patient is a 83 y.o. female patient of with history of CAD with stents ,hypertension ,anxiety, diastolic CHF, hyperlipidemia,and seizures presented to Hospital with leg weakness, fever, nasal congestin and was found to have COVID 19 infection, her husband also has COVID 19.    Lower extremity weakness r/o CVA SIRS Fever-resolved Acute on Chronic low back pain T-max 101.2 CT brain - negative for acute process MRI brain-no acute intracranial process or recent infarction CTA head/neck- no acute intracranial process UA- negative Urine Cx-negative Neurology signed off- follow up as needed PT/OT Care management Monitor CBC   Covid-19 Virus Infection Date of onset of symptoms: 10/21/22 Symptoms present on admission: yes Date of covid positive test: 10/21/22 Vaccination status: vaccinated Imaging: Chest x-ray-no focal pneumonia Oxygen requirements on admission: none Current oxygen requirements: none Medical therapy:Remdesivir-completed 3 days Consultants following: ID consulted Anticipated special isolation end date: 10/31/22   CRP, (86) Sedrate (41) D-dimer (0.57) ferritin(424) LDH (174) Sputum Cx-normal flora, many WBC Incentive Spirometry pen Inhalers prn Oxygen prn Encourage prone positioning   CAD Hypertension Hyperlipidemia History of stents 7 years ago Continue ASA, Losartan,  Plavix, Crestor Monitor BP, BP stable   Chronic Diastolic CHF Echocardiogram-pending- previous Echo 3/5/21-left ventricular diastolic function is grade 1, EF 58% Continue Lasix, Spirolactone Daily weights Strict I & O's   History of seizures Last seizure 15 years ago Continue Dilantin Seizure precautions Neurology -signed off follow up as needed   Incomplete micturition Patient void spontaneously however has to self cath twice a day and this has prevented her from having recurrent UTIs per urology Patient remains on low-dose trimethoprim daily No urinary symptoms
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging head normal, Malaise, Micturition disorder, Muscular weakness, Nasal congestion
Clinical narrative: Patient is a 83 y.o. female patient of with history of CAD with stents ,hypertension ,anxiety, diastolic CHF, hyperlipidemia,and seizures presented to Hospital with leg weakness, fever, nasal congestin and was found to have COVID 19 infection, her husband also has COVID 19.    Lower extremity weakness r/o CVA SIRS Fever-resolved Acute on Chronic low back pain T-max 101.2 CT brain - negative for acute process MRI brain-no acute intracranial process or recent infarction CTA head/neck- no acute intracranial process UA- negative Urine Cx-negative Neurology signed off- follow up as needed PT/OT Care management Monitor CBC   Covid-19 Virus Infection Date of onset of symptoms: 10/21/22 Symptoms present on admission: yes Date of covid positive test: 10/21/22 Vaccination status: vaccinated Imaging: Chest x-ray-no focal pneumonia Oxygen requirements on admission: none Current oxygen requirements: none Medical therapy:Remdesivir-completed 3 days Consultants following: ID consulted Anticipated special isolation end date: 10/31/22   CRP, (86) Sedrate (41) D-dimer (0.57) ferritin(424) LDH (174) Sputum Cx-normal flora, many WBC Incentive Spirometry pen Inhalers prn Oxygen prn Encourage prone positioning   CAD Hypertension Hyperlipidemia History of stents 7 years ago Continue ASA, Losartan,  Plavix, Crestor Monitor BP, BP stable   Chronic Diastolic CHF Echocardiogram-pending- previous Echo 3/5/21-left ventricular diastolic function is grade 1, EF 58% Continue Lasix, Spirolactone Daily weights Strict I & O's   History of seizures Last seizure 15 years ago Continue Dilantin Seizure precautions Neurology -signed off follow up as needed   Incomplete micturition Patient void spontaneously however has to self cath twice a day and this has prevented her from having recurrent UTIs per urology Patient remains on low-dose trimethoprim daily No urinary symptoms
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Red blood cell sedimentation rate increased, SARS-CoV-2 test positive, Serum ferritin increased, Sputum culture
Clinical narrative: Patient is a 83 y.o. female patient of with history of CAD with stents ,hypertension ,anxiety, diastolic CHF, hyperlipidemia,and seizures presented to Hospital with leg weakness, fever, nasal congestin and was found to have COVID 19 infection, her husband also has COVID 19.    Lower extremity weakness r/o CVA SIRS Fever-resolved Acute on Chronic low back pain T-max 101.2 CT brain - negative for acute process MRI brain-no acute intracranial process or recent infarction CTA head/neck- no acute intracranial process UA- negative Urine Cx-negative Neurology signed off- follow up as needed PT/OT Care management Monitor CBC   Covid-19 Virus Infection Date of onset of symptoms: 10/21/22 Symptoms present on admission: yes Date of covid positive test: 10/21/22 Vaccination status: vaccinated Imaging: Chest x-ray-no focal pneumonia Oxygen requirements on admission: none Current oxygen requirements: none Medical therapy:Remdesivir-completed 3 days Consultants following: ID consulted Anticipated special isolation end date: 10/31/22   CRP, (86) Sedrate (41) D-dimer (0.57) ferritin(424) LDH (174) Sputum Cx-normal flora, many WBC Incentive Spirometry pen Inhalers prn Oxygen prn Encourage prone positioning   CAD Hypertension Hyperlipidemia History of stents 7 years ago Continue ASA, Losartan,  Plavix, Crestor Monitor BP, BP stable   Chronic Diastolic CHF Echocardiogram-pending- previous Echo 3/5/21-left ventricular diastolic function is grade 1, EF 58% Continue Lasix, Spirolactone Daily weights Strict I & O's   History of seizures Last seizure 15 years ago Continue Dilantin Seizure precautions Neurology -signed off follow up as needed   Incomplete micturition Patient void spontaneously however has to self cath twice a day and this has prevented her from having recurrent UTIs per urology Patient remains on low-dose trimethoprim daily No urinary symptoms
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Urine analysis normal
Clinical narrative: Patient is a 83 y.o. female patient of with history of CAD with stents ,hypertension ,anxiety, diastolic CHF, hyperlipidemia,and seizures presented to Hospital with leg weakness, fever, nasal congestin and was found to have COVID 19 infection, her husband also has COVID 19.    Lower extremity weakness r/o CVA SIRS Fever-resolved Acute on Chronic low back pain T-max 101.2 CT brain - negative for acute process MRI brain-no acute intracranial process or recent infarction CTA head/neck- no acute intracranial process UA- negative Urine Cx-negative Neurology signed off- follow up as needed PT/OT Care management Monitor CBC   Covid-19 Virus Infection Date of onset of symptoms: 10/21/22 Symptoms present on admission: yes Date of covid positive test: 10/21/22 Vaccination status: vaccinated Imaging: Chest x-ray-no focal pneumonia Oxygen requirements on admission: none Current oxygen requirements: none Medical therapy:Remdesivir-completed 3 days Consultants following: ID consulted Anticipated special isolation end date: 10/31/22   CRP, (86) Sedrate (41) D-dimer (0.57) ferritin(424) LDH (174) Sputum Cx-normal flora, many WBC Incentive Spirometry pen Inhalers prn Oxygen prn Encourage prone positioning   CAD Hypertension Hyperlipidemia History of stents 7 years ago Continue ASA, Losartan,  Plavix, Crestor Monitor BP, BP stable   Chronic Diastolic CHF Echocardiogram-pending- previous Echo 3/5/21-left ventricular diastolic function is grade 1, EF 58% Continue Lasix, Spirolactone Daily weights Strict I & O's   History of seizures Last seizure 15 years ago Continue Dilantin Seizure precautions Neurology -signed off follow up as needed   Incomplete micturition Patient void spontaneously however has to self cath twice a day and this has prevented her from having recurrent UTIs per urology Patient remains on low-dose trimethoprim daily No urinary symptoms
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine had expired 8/31/22
Age: 10.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: pt receeved the bivalent booster dose for the 2nd dose in the primary series instead of the primary vaccine dose; pt had no reaction to the vaccine
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine had expired on 8/31/22
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: Contusion, Feeling hot, Immediate post-injection reaction, Loss of personal independence in daily activities, Mobility decreased
Clinical narrative: Customer immediately felt arm hurt, it was hot, then got black and blue, one week later...trouble moving backwards, patient as of now cannot put bra on and cannot fix hair with left arm
Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain in extremity
Clinical narrative: Customer immediately felt arm hurt, it was hot, then got black and blue, one week later...trouble moving backwards, patient as of now cannot put bra on and cannot fix hair with left arm
Age: 30.0
Sex: F
Vaccine: COVID19-2
Symptoms: Antinuclear antibody positive, Dizziness, Fatigue, Feeling abnormal, Hot flush
Clinical narrative: Four days later, fatigue. Fatigue was extreme for one week, let up for one week, and then returned and has persisted. Brain fog, overwhelm, high sensitivity to sensory input, dizziness, hot flashes, nausea.  Previous COVID infection in early June.
Age: 30.0
Sex: F
Vaccine: COVID19-2
Symptoms: Nausea, Sensory overload, Sensory processing sensitivity
Clinical narrative: Four days later, fatigue. Fatigue was extreme for one week, let up for one week, and then returned and has persisted. Brain fog, overwhelm, high sensitivity to sensory input, dizziness, hot flashes, nausea.  Previous COVID infection in early June.
Age: 0.5
Sex: F
Vaccine: RV1
Symptoms: Barium double contrast, Intussusception, Ultrasound scan
Clinical narrative: Intuss at day 21 post vaccination
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine had expired in 8/31/22
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Acute kidney injury, Acute myocardial infarction, Arthralgia, Breast cancer metastatic, COVID-19
Clinical narrative: This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated 4 times with the Pfizer product, having received vaccine on 01/28/2021, 02/18/2021, 08/26/2021 and 06/01/2022. They presented to emergency department on 09/01/2022 for shoulder pain and were discharged with medication. They presented to emergency department again on 09/02/2022 via EMS for fever and change in mental status/new confusion. They tested positive for COVID-19 on 09/02/2022 (upon hospital admission). They had a highly complex medical history and were on chemotherapy for multiple metastasized cancer. They were found to be septic due to Enterobacter and in acute renal failure. They also had suffered a non-ST elevated myocardial infarction. The individual was revised to DNR due to poor prognosis and they died in hospital on 09/04/2022.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Confusional state, Death, Enterobacter sepsis, Mental status changes, Pyrexia
Clinical narrative: This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated 4 times with the Pfizer product, having received vaccine on 01/28/2021, 02/18/2021, 08/26/2021 and 06/01/2022. They presented to emergency department on 09/01/2022 for shoulder pain and were discharged with medication. They presented to emergency department again on 09/02/2022 via EMS for fever and change in mental status/new confusion. They tested positive for COVID-19 on 09/02/2022 (upon hospital admission). They had a highly complex medical history and were on chemotherapy for multiple metastasized cancer. They were found to be septic due to Enterobacter and in acute renal failure. They also had suffered a non-ST elevated myocardial infarction. The individual was revised to DNR due to poor prognosis and they died in hospital on 09/04/2022.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated 4 times with the Pfizer product, having received vaccine on 01/28/2021, 02/18/2021, 08/26/2021 and 06/01/2022. They presented to emergency department on 09/01/2022 for shoulder pain and were discharged with medication. They presented to emergency department again on 09/02/2022 via EMS for fever and change in mental status/new confusion. They tested positive for COVID-19 on 09/02/2022 (upon hospital admission). They had a highly complex medical history and were on chemotherapy for multiple metastasized cancer. They were found to be septic due to Enterobacter and in acute renal failure. They also had suffered a non-ST elevated myocardial infarction. The individual was revised to DNR due to poor prognosis and they died in hospital on 09/04/2022.
Age: 5.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: patient received the pfizer bivalent vaccine instead of the primary series for pfizer for his first COVID vaccine. MA incorrectly read the verified the order against the vaccine before giving. no s/sxs following administration error.
Age: 62.0
Sex: M
Vaccine: COVID19-2
Symptoms: Dizziness, Fatigue, Headache, Insomnia, Malaise
Clinical narrative: Dizziness, headache, tiredness, insomnia, malaise occuring daily for hours at a time.
Age: 63.0
Sex: M
Vaccine: FLUC4
Symptoms: Syncope
Clinical narrative: Fainted about 10 minutes after vaccination, on the sidewalk after leaving store. A passer-by called for an ambulance. Patient was taken to Hospital and was cleared with no further injuries.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine had expired on 8/31/22
Age: 5.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: patient received the pfizer bivalent vaccine instead of the primary series for pfizer for his first COVID vaccine. MA incorrectly read the verified the order against the vaccine before giving. no s/sxs following administration error.
Age: 60.0
Sex: F
Vaccine: COVID19-2
Symptoms: Abdominal pain upper, Blood test, Cholecystectomy, Cholecystitis, Cholelithiasis
Clinical narrative: Received dose on 10/26/22 and that evening had fever, enlarged lymph node under right arm pit, flu like symptoms.felt better next day. On 10/29/22 I started having stomach pains which continued off and on. Contacted primary doctor on 10/31 and instructed to go urgent care or emergency if gets worse.  Felt better next day but the following days pain would come and go. On 11/11/22 the pain was so intense I wen to emergency. They sent me home after giving me zofran and  toridal.  On 11/15/22 I went to follow up  with PA in primary dr. Office. She scheduled Ultrasound for 12/5. Later that evening on 11/15 the pain was so bad that I went to emergency and found that my gallbladder was inflamed. Surgery to remove gallbladder on 11/16/22.
Age: 60.0
Sex: F
Vaccine: COVID19-2
Symptoms: Computerised tomogram, Influenza like illness, Lymphadenopathy, Pyrexia, Ultrasound biliary tract
Clinical narrative: Received dose on 10/26/22 and that evening had fever, enlarged lymph node under right arm pit, flu like symptoms.felt better next day. On 10/29/22 I started having stomach pains which continued off and on. Contacted primary doctor on 10/31 and instructed to go urgent care or emergency if gets worse.  Felt better next day but the following days pain would come and go. On 11/11/22 the pain was so intense I wen to emergency. They sent me home after giving me zofran and  toridal.  On 11/15/22 I went to follow up  with PA in primary dr. Office. She scheduled Ultrasound for 12/5. Later that evening on 11/15 the pain was so bad that I went to emergency and found that my gallbladder was inflamed. Surgery to remove gallbladder on 11/16/22.
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Axillary pain, Pain, Rash
Clinical narrative: DEVELOPED PAINFUL SORE IN ONE AXILLA THE MORNING AFTER ADMINISTRATION.  (PT DID NOT RECALL WHICH SIDE IT DEVELOPED INITIALLY).  THEN DEVELOPED SMALLER "MOSQUITO BITE" SIZED BUMPS ON STOMACH AND BUTTOCKS OVER THE NEXT DAY (ABOUT 7 BUMPS IN EACH AREA).   PT ALSO HAD BODY ACHES AFTER VACCINATION.  NO FEVER.   ADVISED PT TO CHECK IN WITH PCP.
Age: 81.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: Patient was given 2 0.5ml doses of Moderna bivalent.    He also received the flu vaccine.  Patient was observed for 15 minutes after error and reported feeling no changes.
Age: 59.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blood test, Condition aggravated, Dizziness, Electrocardiogram, Heart rate increased
Clinical narrative: Within 5 minutes of receiving vaccine: Heart palpitations and feelings of very fast heartbeat, very high blood pressure (over 200/100), heat flash in chest, dizziness.
Age: 59.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hot flush, Hypertension, Immediate post-injection reaction, Palpitations, Pneumonitis
Clinical narrative: Within 5 minutes of receiving vaccine: Heart palpitations and feelings of very fast heartbeat, very high blood pressure (over 200/100), heat flash in chest, dizziness.
Age: 59.0
Sex: F
Vaccine: COVID19-2
Symptoms: Urine analysis
Clinical narrative: Within 5 minutes of receiving vaccine: Heart palpitations and feelings of very fast heartbeat, very high blood pressure (over 200/100), heat flash in chest, dizziness.
Age: 52.0
Sex: F
Vaccine: COVID19-2
Symptoms: Syringe issue, Underdose
Clinical narrative: While administering the vaccine the syringe/needle leaked from the joint of the needle/syringe.  The amount of vaccine the patient actually received couldn't be determined.
Age: 69.0
Sex: M
Vaccine: COVID19-2, FLUR4
Symptoms: Extra dose administered
Clinical narrative: DRUG ERROR, PATIENT ALREADY GOT FLUZONE HD 9/19/22 AND CAME IN AND GOT FLUBLOK 11/16/22
Age: 71.0
Sex: M
Vaccine: COVID19-2
Symptoms: Chromaturia, Computerised tomogram abnormal, Faeces pale, Liver disorder
Clinical narrative: Started having 2 weeks of light colored stools and dark urine,  CT showed hepatic duct dilation, and abd showed possible renal cell carcinoma
Age: 83.0
Sex: F
Vaccine: FLUA4
Symptoms: Injection site erythema, Injection site hypersensitivity, Injection site inflammation, Injection site pruritus, Injection site rash
Clinical narrative: Received a phone call today with patient stating that since the flu vaccine, she has been experiencing inflammation and reddish, itchy rash around the injection site. The inflammation has subsided but still has a rash and is sensitive.  No other symptoms are noted and it has been two weeks since.
Age: 63.0
Sex: F
Vaccine: FLU4
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient stated her oncologist wanted her to receive the High dose due to receiving cancer treatment and had a note from her PCP in her chart.
Age: 16.0
Sex: F
Vaccine: MENB
Symptoms: Dizziness
Clinical narrative: Dizziness post-vaccination, resolved after pt waited for approximately 20min.
Age: 15.0
Sex: F
Vaccine: FLU4
Symptoms: Dizziness, Fatigue, Headache, Influenza virus test negative, Loss of consciousness
Clinical narrative: Patient and parent are unsure of exact brand of influenza vaccine.  Patient received the vaccine on 11/14, reported having body aches starting 11/15. Then while taking a shower on 11/16 felt dizzy, laid down in her bed and briefly lost consciousness. She reports having sore throat, headache, fatigue, and fever temp max 102 also. Feeling improved on 11/17
Age: 15.0
Sex: F
Vaccine: FLU4
Symptoms: Oropharyngeal pain, Pain, Pyrexia, SARS-CoV-2 test negative, Streptococcus test negative
Clinical narrative: Patient and parent are unsure of exact brand of influenza vaccine.  Patient received the vaccine on 11/14, reported having body aches starting 11/15. Then while taking a shower on 11/16 felt dizzy, laid down in her bed and briefly lost consciousness. She reports having sore throat, headache, fatigue, and fever temp max 102 also. Feeling improved on 11/17
Age: 73.0
Sex: M
Vaccine: TDAP
Symptoms: Injection site pain, Mobility decreased
Clinical narrative: Shortly after receiving the vaccine, my arm began to hurt at the injection site and continues to this day.   It is difficult to lift items with my left arm due to pain.
Age: 4.0
Sex: F
Vaccine: FLU4, HEP, IPV, MMRV
Symptoms: Lethargy, Lymphadenopathy, Pyrexia
Clinical narrative: 11/16/22: Received message from Appointment Desk stating parent of patient, states child is having a reaction to her vaccines done on 11/10/22. Wanted us to know. Mom is taking child to Urgent Care.  11/17/22: Called mother, left message to call back. Mother called back, states child was taken to urgent care yesterday after developing left gland swelling from ear lobe to shoulder. States child was prescribed antibiotic in case of infection and anti-inflammatory medication. States doctor said it could have been a reaction to the vaccines. States child had high temps and lethargy for 4 days after receiving vaccinations. States child had received all vaccinations previously with no issues. This was the first time receiving the flu vaccine. Advised to continue care per urgent care instructions and follow up with doctor as needed. Advised will submit a VAERS report with information provided.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood test, Cardiovascular disorder, Dyspnoea, Electrocardiogram abnormal, Fatigue
Clinical narrative: Tiredness and sleep with the first dose. Tiredness, sleepiness, tremor on the second dose. Approximately by September 2021 body aches, headache, palpitations, shortness of breath. At the end diagnosis of cardiovascular disease in October 2021
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain, Somnolence, Tremor
Clinical narrative: Tiredness and sleep with the first dose. Tiredness, sleepiness, tremor on the second dose. Approximately by September 2021 body aches, headache, palpitations, shortness of breath. At the end diagnosis of cardiovascular disease in October 2021
Age: 60.0
Sex: M
Vaccine: COVID19-2
Symptoms: Extra dose administered
Clinical narrative: please note! there was not an adverse reaction- there was  an unintentionally given extra bivalent dose- patient had a bivalent dose on 1 month prior
Age: 33.0
Sex: F
Vaccine: COVID19, UNK
Symptoms: Seizure
Clinical narrative: Mild seizure for the first time in my life
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Received bivalent booster 09/17/2022 and did not report at time of vaccination. Vaccine administered 11/17/2022 was second bivalent booster received in total. Patient was notified and reported no side effects. Instructed to report any concerns and seek medical attention if necessary.
Age: 61.0
Sex: M
Vaccine: COVID19-2
Symptoms: Arthralgia, Mobility decreased, Pain
Clinical narrative: Per patient description, shoulder very sore, achy, motion inhibited, hurts on and off.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: PATIENT WANTED OMICRON BOOSTER BUT WAS GIVEN UNDILUTED PFIZER PEDIATRIC ON 11/17/22. MULTIPLE ATTEMPTS MADE TO REACH PATIENT BUT NO RESPONSE. NO KNOWN EVENTS.
Age: 43.0
Sex: M
Vaccine: COVID19-2
Symptoms: Anticoagulant therapy, Blood test abnormal, Cerebral venous sinus thrombosis, Factor II mutation, Headache
Clinical narrative: Severe headache caused me to go to the emergency room where an MRI was administered to confirm a diagnosis of a dural venous sinus thrombosis 2 weeks after my last vaccine booster dose.  I was hospitalized for three days in blood thinners and have been prescribed / advised to take eliquis blood thinners long term as this is the second clotting issue I?ve had in my life (I?ve had a DVT in the past)
Age: 43.0
Sex: M
Vaccine: COVID19-2
Symptoms: Magnetic resonance imaging head abnormal
Clinical narrative: Severe headache caused me to go to the emergency room where an MRI was administered to confirm a diagnosis of a dural venous sinus thrombosis 2 weeks after my last vaccine booster dose.  I was hospitalized for three days in blood thinners and have been prescribed / advised to take eliquis blood thinners long term as this is the second clotting issue I?ve had in my life (I?ve had a DVT in the past)
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache, Injection site erythema
Clinical narrative: Patients mother called the office stating  " Her Left upper arm is swollen red and warm to touch. She complains about it being sore. She is experiencing dizziness, headache, chills, mild fever, fatigue and pain going down the arm.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Injection site warmth, Pain, Pain in extremity, Pyrexia
Clinical narrative: Patients mother called the office stating  " Her Left upper arm is swollen red and warm to touch. She complains about it being sore. She is experiencing dizziness, headache, chills, mild fever, fatigue and pain going down the arm.
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash, Rash erythematous, Rash pruritic
Clinical narrative: Red, itchy rash on inside elbows, wrists, neck and chest.  Claritin and topical Benadryl, plus coconut oil with CBD.   Still increasing as of November 17, 2022 - two weeks.
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash erythematous, Rash pruritic
Clinical narrative: Red, itchy rash on inside elbows, wrists, neck and chest.  Claritin and topical Benadryl, plus coconut oil with CBD.   Still increasing as of November 17, 2022 - two weeks.
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Chills, Cough, Fatigue, Nasal congestion
Clinical narrative: Cold symptoms starting on 11/7/22 and worsening over 2 days.  Symptoms included frequent dry cough, nasal congestion, fatigue, and chills.  I would describe it as the worse cold I have had.
Age: 75.0
Sex: F
Vaccine: COVID19-2
Symptoms: Nasopharyngitis, SARS-CoV-2 test positive
Clinical narrative: Cold symptoms starting on 11/7/22 and worsening over 2 days.  Symptoms included frequent dry cough, nasal congestion, fatigue, and chills.  I would describe it as the worse cold I have had.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event, Product preparation issue
Clinical narrative: PATIENT WANTED OMICRON BOOSTER AND RECIEVED UNDILUTED PFIZER PEDIATRIC. PATIENT MADE AWARE. PER CDC PATIENT COULD RECEIVE OMICRON IMMEDIATELY OR WAIT 2 MONTHS. PATIENT CHOSE TO WAIT 2 MONTHS. NO ADVERSE EFFECTS REPORTED.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event, Product preparation issue
Clinical narrative: PATIENT WANTED OMICRON BOOSTER BUT RECEIVED UNDILUTED PEDIATRIC PFIZER. PER CDC PATIENT COULD RECEIVE OMICRON SHOT NOW OR WAIT 2 MONTHS. PATIENT WILL RETURN 11/18/22 TO REDO SHOT. NO ADVERSE EFFECTS REPORTED.
Age: 70.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: COVID-19 mRNA LNP-S, bivalent PF 12yrs-adult booster (Pfizer), 30mcg/0.3mL - was given instead of 2nd dose of Primary Series
Age: 44.0
Sex: F
Vaccine: COVID19-2
Symptoms: Abdominal discomfort, Dizziness, Loss of consciousness
Clinical narrative: passed out after getting pfizer bival and fluarix vaccines.  stomach upset and lightheaded.  patient then informed that this has happened before.  called 911 and gave water observed until ambulance arrived. they took blood pressure and questioned.  pt refused to go to hospital.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: We believe a monovalent dose for age 5-11 was given instead of the bivalent booster.
Age: 84.0
Sex: F
Vaccine: FLUA4
Symptoms: Injected limb mobility decreased, Injection site bruising, Injection site swelling, Injection site warmth
Clinical narrative: started out hot, swollen. warmth at area of injection resolved but was followed by significant bruising and patient reported decreased ability to use her arm. bruising continued to spread down past her elbow in a couple days time.
Age: 47.0
Sex: M
Vaccine: COVID19-2
Symptoms: Rash, Swelling
Clinical narrative: Prolong  rash. Body swelling. Intense for about a week and off and on for more than a month now.
Age: 27.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient has not reported any adverse events, but they received the Moderna Bivalent booster as their 2nd shot when they only received 1 monovalent Pfizer shot
Age: 52.0
Sex: F
Vaccine: COVID19-2, FLUR4
Symptoms: Dizziness, Headache, Immediate post-injection reaction, Muscular weakness, Nausea
Clinical narrative: PATIENT RECEIVED FLU AND MODERNA VACCINE AT 430PM. PATIENT WAS DOING FINE AND BEGAN GROCERY SHOPPING 5-10 MINUTES AFTER VACCINES. PATIENT BEGAN TO FEEL WEAKNESS IN LEGS AND SAT ON THE FLOOR WITH HEADACHE AND DIZZINESS  AND NAUSEA. PARAMEDICS WERE CALLED AND PATIENT WAS TAKEN TO THE HOSPITAL. PATIENT WAS AWAKE AND ALERT THE ENTIRE TIME. NO ISSUES WITH BREATHING.
Age: 29.0
Sex: F
Vaccine: ANTH
Symptoms: Erythema, Hypoaesthesia, Swelling face
Clinical narrative: Face numbness, face redness, cheek swelling.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Fluid intake reduced, Full blood count, Nausea, Urine analysis, Vomiting
Clinical narrative: Severe nausea and vomiting that presented gradually (about 24 hours after receiving the Covid booster), then quickly became so severe that I could not even tolerate fluids or sips of water. I eventually had to go to emergency room on January 9, 2022, after 4 days of vomiting and inability to tolerate fluids, where I was given the anti-nausea medicine ondansetron via an I.V., and a prescription for more to stop the vomiting.
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Anticoagulant therapy, Aortic dilatation, Atrial fibrillation, Cardiac stress test normal, Computerised tomogram coronary artery
Clinical narrative: First noticed tachycardia on 3/23/21, a few weeks after second dose which was on 2/19/21. In June 2021 was diagnosed with possible Afib by cardiologist, and then later diagnosed by an EP in December 2021. Prior to the vaccines I had no diagnosis of any cardio problems, and had not noticed any tachycardia.  After multiple tests, had a calcium score of 38 and a mildly dilated aortic root, and some moderate mitral regurgitation. Stress tests, regular and nuclear are normal. Am now taking a blood thinner and statin.
Age: 56.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Laboratory test, Mitral valve incompetence, Scan myocardial perfusion, Tachycardia
Clinical narrative: First noticed tachycardia on 3/23/21, a few weeks after second dose which was on 2/19/21. In June 2021 was diagnosed with possible Afib by cardiologist, and then later diagnosed by an EP in December 2021. Prior to the vaccines I had no diagnosis of any cardio problems, and had not noticed any tachycardia.  After multiple tests, had a calcium score of 38 and a mildly dilated aortic root, and some moderate mitral regurgitation. Stress tests, regular and nuclear are normal. Am now taking a blood thinner and statin.
Age: 45.0
Sex: F
Vaccine: COVID19-2
Symptoms: Fluid intake reduced, Nausea, Vomiting
Clinical narrative: Severe nausea and vomiting that began within 12 hours after receiving the bivalent Covid booster that was so severe I could not tolerate fluids, even sips of water. Vomiting persisted for next 4 days until I eventually had to go to urgent care for prescription of ondansetron to stop vomiting.
Age: 66.0
Sex: F
Vaccine: FLU4
Symptoms: Infection, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Patient had a red, hot and swollen arm from the site of injection to her elbow.  She received an antibiotic from the emergency room.  She picked up antibiotic two days after injection of vaccine.
Age: 80.0
Sex: M
Vaccine: FLU4
Symptoms: Blood magnesium normal, Electroencephalogram normal, Magnetic resonance imaging normal, Malaise, Seizure
Clinical narrative: Pt. is an 80 y/o man with past medical history of HTN, HLD , HFimpEF (2/2 chemo; no h/o hospitalizations), CAD (s/p PCI to LAD 2019), DLBCL (s/p CHOP 2002), hodgkins lymphoma (s/p ABVD 2012), secondary pulm HTN, melanoma (T3bNxM0 Dx 2/2022, scalp, s/p excision), hypogonadism, BPH w/ elevated PSA who presented to my clinic today for hospital follow-up.  He received the flu shot two weeks ago and that night had a first-time lifetime seizure.  He was admitted to the hospital. MRI was unremarkable. EEG was unremarkable. His magnesium was 1.5 which may have contributed. Otherwise no cause has been identified. Of note, he has melanoma so I plan to repeat MRI in 3 months with hopes that this is not an occult brain metastasis that caused this. Other than the above discussion, I do not know a clear cause of his seizure. He was not feeling well that evening, perhaps reasonably due to immune response from the shot.
Age: 41.0
Sex: M
Vaccine: COVID19-2
Symptoms: Chest pain, Dyspnoea, Palpitations
Clinical narrative: Same day after a couple of hours I felt chest pain and shortness of breath,. I was feeling a pounding heart. I got much better after 2-3 days, but tried to relax, not going to ER. I was very close to get to the hospital.
Age: 33.0
Sex: F
Vaccine: COVID19-2
Symptoms: Tinnitus
Clinical narrative: tinnitus - ringing in ears - high-pitched
Age: 9.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: pt was given 0.5ml of bivalent moderna covid 19 vaccine in stead of 0.25ml of dosage. Patient's father was notified, he was okay with the incident. No reaction to the patient notified from the father as of now
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: Within 2 hours I was in bed with a fever, chills, aches, and immense pain that can only be described as being crushed all over.
Age: 8.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: patient was given 0.5ml of dosage in stead of 0.25ml
Age: 96.0
Sex: F
Vaccine: COVID19-2
Symptoms: Supraventricular tachycardia
Clinical narrative: Episodes of paroxysmal supraventricular tachycardia requiring hospitalization with 3 ER visits
Age: 7.0
Sex: F
Vaccine: FLU4
Symptoms: Erythema, Induration
Clinical narrative: large amount of erythema and induration over entire deltoid, tracking down to elbow.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Patient received a monolent Pfizer Covid 19 vaccine on 11/17/22, after having received Janssen on 03/13/2021 and a Janssen Booster on 12/23/2021.
Age: 9.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, Product preparation error
Clinical narrative: Pfizer bivalent 5y-11 vial not diluted & given to two patients.  RN discovered it & questioned LPN that prepared the vial, The Nurse manager is aware & practice manager as well. Father received a call also
Age: 9.0
Sex: M
Vaccine: DTAP, FLU4, VARCEL
Symptoms: No adverse event
Clinical narrative: No reaction
Age: 16.0
Sex: M
Vaccine: FLU4, HPV9, MENB
Symptoms: Injection site erythema, Injection site pain
Clinical narrative: Redness to L arm post inj. 3 days - > 2", tender to touch. pt was out of town - went to urgent care - Rx - Antibiotics Bactrim
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Had a sore arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Had a sore arm) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination.     The patient's past medical history included Metastasis (abdomen metastasis removed on 2019) in 2019, Nephrectomy in 2017 and Appendicitis (unknown of status such as improvement or worsening). Concurrent medical conditions included Allergy to antibiotic, Bladder cancer (malignant tumor with abdomen metastasis removed on 2019, patient made a CT scan and PET scan and doctors noticed cancer spread again) since 2010 and Pain kidney.    On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced PAIN IN EXTREMITY (Had a sore arm). At the time of the report, PAIN IN EXTREMITY (Had a sore arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medication reported. No treatment medication reported.   This case was linked to MOD21-132152 (E2B Linked Report). This case was linked to MOD-2021-674168, MOD-2022-673532, MOD-2022-673536, MOD-2021-291235 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 16-Nov-2022: Live follow-up received on 16-Nov-2022 with Medical history updated.; Sender's Comments:  MOD21-132152:
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Chest pain, Dizziness, Fatigue, Headache
Clinical narrative: Dizziness; nausea; fever; chest pain; high blood pressure; headache; fatigue; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 38-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 31Aug2021 at 13:00 as dose 1, single (Lot number: FC3180) at the age of 38 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hydrodentis suprateva" (unspecified if ongoing); "Chronic migraines" (unspecified if ongoing). Concomitant medication(s) included: OMEGA3 JACK; IRON; B12 [CYANOCOBALAMIN]; TRAMADOL; MINOCYCLINE. The following information was reported: DIZZINESS (non-serious) with onset 31Aug2021 at 13:00, outcome "not recovered"; CHEST PAIN (non-serious) with onset 31Aug2021 at 13:00, outcome "not recovered"; FATIGUE (non-serious) with onset 31Aug2021 at 13:00, outcome "not recovered"; PYREXIA (non-serious) with onset 31Aug2021 at 13:00, outcome "not recovered", described as "fever"; HEADACHE (non-serious) with onset 31Aug2021 at 13:00, outcome "not recovered"; HYPERTENSION (non-serious) with onset 31Aug2021 at 13:00, outcome "not recovered", described as "high blood pressure"; NAUSEA (non-serious) with onset 31Aug2021 at 13:00, outcome "not recovered". The events "dizziness", "nausea", "fever", "chest pain", "high blood pressure", "headache" and "fatigue" required physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of dizziness, nausea, pyrexia, chest pain, hypertension, headache, fatigue.  Additional information: Adverse event treatments were Iprofen, prednisone, amlodipine and hydrochlorothiazide. Patient was not diagnosed with Covid-19 prior to vaccination.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Nausea, Pyrexia, SARS-CoV-2 test
Clinical narrative: Dizziness; nausea; fever; chest pain; high blood pressure; headache; fatigue; This is a spontaneous report received from contactable reporter(s) (Other HCP). The reporter is the patient.  A 38-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 31Aug2021 at 13:00 as dose 1, single (Lot number: FC3180) at the age of 38 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hydrodentis suprateva" (unspecified if ongoing); "Chronic migraines" (unspecified if ongoing). Concomitant medication(s) included: OMEGA3 JACK; IRON; B12 [CYANOCOBALAMIN]; TRAMADOL; MINOCYCLINE. The following information was reported: DIZZINESS (non-serious) with onset 31Aug2021 at 13:00, outcome "not recovered"; CHEST PAIN (non-serious) with onset 31Aug2021 at 13:00, outcome "not recovered"; FATIGUE (non-serious) with onset 31Aug2021 at 13:00, outcome "not recovered"; PYREXIA (non-serious) with onset 31Aug2021 at 13:00, outcome "not recovered", described as "fever"; HEADACHE (non-serious) with onset 31Aug2021 at 13:00, outcome "not recovered"; HYPERTENSION (non-serious) with onset 31Aug2021 at 13:00, outcome "not recovered", described as "high blood pressure"; NAUSEA (non-serious) with onset 31Aug2021 at 13:00, outcome "not recovered". The events "dizziness", "nausea", "fever", "chest pain", "high blood pressure", "headache" and "fatigue" required physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of dizziness, nausea, pyrexia, chest pain, hypertension, headache, fatigue.  Additional information: Adverse event treatments were Iprofen, prednisone, amlodipine and hydrochlorothiazide. Patient was not diagnosed with Covid-19 prior to vaccination.
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: A-FIB; worsening heart palpitations; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A 91-year-old patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Sep2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series completed but Manufacturer unknown), for Covid-19 Immunization; Covid-19 vaccine (dose:3, Manufacturer unknown), for Covid-19 Immunization. The following information was reported: ATRIAL FIBRILLATION (death, medically significant) with onset 2022, outcome "fatal", described as "A-FIB"; PALPITATIONS (death) with onset 2022, outcome "fatal", described as "worsening heart palpitations". The patient date of death was unknown. Reported cause of death: "worsening heart palpitations", "A-FIB". It was not reported if an autopsy was performed. The patient died. 3 weeks after Omicron Vac started having worsening heart palpitation, A-fib After shots.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: worsening heart palpitations; A-FIB
Sex: U
Vaccine: COVID19, COVID19, COVID19
Symptoms: Atrial fibrillation, Palpitations
Clinical narrative: A-FIB; worsening heart palpitations; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A 91-year-old patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 28Sep2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series completed but Manufacturer unknown), for Covid-19 Immunization; Covid-19 vaccine (dose:3, Manufacturer unknown), for Covid-19 Immunization. The following information was reported: ATRIAL FIBRILLATION (death, medically significant) with onset 2022, outcome "fatal", described as "A-FIB"; PALPITATIONS (death) with onset 2022, outcome "fatal", described as "worsening heart palpitations". The patient date of death was unknown. Reported cause of death: "worsening heart palpitations", "A-FIB". It was not reported if an autopsy was performed. The patient died. 3 weeks after Omicron Vac started having worsening heart palpitation, A-fib After shots.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: worsening heart palpitations; A-FIB